Evidence map›Paper›PMID 30364516›Full record

ArticleCurrent treatment options in psychiatry2018

Identifying and treating the prodromal phases of bipolar disorder and schizophrenia.

Susan Conroy, Michael Francis, Leslie A Hulvershorn

Abstract read
In one paragraph

Article in Current treatment options in psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Schizophrenia Outside the Brain.Advances in experimental medicine and biology · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Susan ConroyDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.
Michael FrancisDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.
Leslie A HulvershornDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.

Funding

Neural Response to Risky Decision Making in Youth at High Risk for Substance Use Disorders and HIVR01DA039764 · NIDA · INDIANA UNIVERSITY INDIANAPOLIS · PI HULVERSHORN, LESLIE A. · 2016 to 2021
$3.3M
NIDA NIH HHS R01 DA039764
6 · The paper itself

Abstract

purpose of reviewThe goal of this paper is to review recent research on the identification and treatment of prodromal periods that precede bipolar and psychotic disorders. We also sought to provide information about current best clinical practices for prodromal youth. RECENT

findingsResearch in the areas of identifying prodromal periods has rapidly advanced. Calculators that can predict risk are now available for use during both bipolar and psychotic disorder prodromes. Cognitive behavior therapies have emerged as the gold standard psychosocial interventions for the psychosis prodrome, while several other types of therapies hold promise for treatment during the bipolar prodrome. Due to safety and efficacy concerns, pharmacologic treatments are not currently recommended during either prodromal period. SUMMARY: While additional research is needed to develop useful clinical tools to screen and diagnose during prodromal phases, existing literature has identified constellations of symptoms that can be reliably identified in research settings. Specialized psychotherapies are currently recommended to treat prodromal symptoms in clinical settings. They may also be useful to curtail future episodes, although further research is needed.

Indexed as

bipolar disorderpsychosis prodromeschizophrenia

Identifiers

PMID30364516
PMCPMC6196741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.